2021
DOI: 10.1177/11769343211014167
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome

Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has motivated a widespread effort to understand its epidemiology and pathogenic mechanisms. Modern high-throughput sequencing technology has led to the deposition of vast numbers of SARS-CoV-2 genome sequences in curated repositories, which have been useful in mapping the spread of the virus around the globe. They also provide a unique opportunity to observe virus evolution in real time. Here, we evaluate two sets of SARS-CoV-2 genomic s… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
63
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(64 citation statements)
references
References 112 publications
(216 reference statements)
1
63
0
Order By: Relevance
“…2A ). Because VA1-s2m 18, 24 was viable despite alteration of the stop codon, this finding suggests that the extension of ORF2 by 16 amino acids does not by itself compromise the viability of VA1. Finally, we determined if we could recover a mutant in which two G-C base pair sites were inverted compared to WT.…”
Section: Resultsmentioning
confidence: 90%
See 4 more Smart Citations
“…2A ). Because VA1-s2m 18, 24 was viable despite alteration of the stop codon, this finding suggests that the extension of ORF2 by 16 amino acids does not by itself compromise the viability of VA1. Finally, we determined if we could recover a mutant in which two G-C base pair sites were inverted compared to WT.…”
Section: Resultsmentioning
confidence: 90%
“…At 96 hpi, viral RNA and titers were reduced for VA1-s2m 12, 18, 24, 33 (RNA: 3.6-fold, P= 0.0014; virus titer: 4.4-fold, P< 0.001), VA1-s2m 12, 33 (RNA: 1.5-fold, P= 0.049; virus titer: 4.9-fold P< 0.001) and VA1-s2m 9 (RNA: 3.3-fold, P< 0.001; virus titer: 6.8-fold, P< 0.001). VA1-s2m 18, 24 had no significant differences in RNA or viral titer (both P> 0.06). These results suggest that some of the recombinant viruses have a growth defect, with VA1-s2m 9 having the greatest reduction at 96 hpi.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations